Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
21.19
+0.32 (1.53%)
At close: Jul 3, 2025, 1:00 PM
21.12
-0.07 (-0.33%)
After-hours: Jul 3, 2025, 1:04 PM EDT
Sionna Therapeutics Employees
Sionna Therapeutics had 41 employees as of December 31, 2024. The number of employees increased by 13 or 46.43% compared to the previous year.
Employees
41
Change (1Y)
13
Growth (1Y)
46.43%
Revenue / Employee
n/a
Profits / Employee
-$1,617,634
Market Cap
934.31M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41 | 13 | 46.43% |
| Dec 31, 2023 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SION News
- 27 days ago - Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model - GlobeNewsWire
- 4 weeks ago - Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis - GlobeNewsWire
- 4 weeks ago - Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference - GlobeNewsWire
- 7 weeks ago - Sionna Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025 - GlobeNewsWire
- 3 months ago - Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 months ago - Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference - GlobeNewsWire